2022;6(6):bvac054
CMS.gov, Medicare GLP-1 Bridge program announcement Wegovy is FDA-approved for chronic weight management (BMI 30+, or 27+ with a weight-related comorbidity) and for cardiovascular risk reduction in adults with established CVD it is a weight-loss and CV drug, not a diabetes drug
However, in this study, only standard exercise guidance, as typically provided in clinical settings, was given
103 Because megacolon is believed to be the end result of chronic dilatation,140, 170 it is the author's firm belief that initial dietary efforts should be directed to reducing fecal bulk and thus introducing a low-residue diet
Furthermore, a supplement may contain a combination of ingredients that have never been tested together, so it is not known if the combination will work even if there is good evidence for one or more of its components
mTOR activation increases ribosomal activity and enhances structural protein assembly within muscle fibers